Solana News: Curetopia Raises $1.77M to Accelerate Decentralized Biotech Research on Solana

In a significant boost for the decentralized science (DeSci) sector, Curetopia has announced the successful raising of $1.77 million in funding. This capital will be used to expedite treatments for rare diseases through a decentralized biotech model leveraging the Solana blockchain. Here’s a closer look at this groundbreaking initiative.

Curetopia Raises $1.77M to Drive Decentralized Biotech Breakthroughs Using Solana

Curetopia has secured $1.77 million in funding to expedite treatments for rare diseases through a decentralized biotech model leveraging Solana. The fundraising effort, supported by more than 1,000 individual contributors, highlights the growing momentum in the decentralized science (DeSci) sector. The Curetopia DAO, launched on Bio Protocol with backing from Binance, seeks to address an estimated $1 trillion rare disease market historically underserved by large pharmaceutical companies. Utilizing blockchain-based crowdfunding, Curetopia enables rare disease patients and researchers to collaboratively finance drug development projects, sharing ownership.

Solana (SOL) Stands at $123.75, BinoFi (BINO)’s Bridge-Free Cross-Chain Capability Gains Traction

Despite a decline from its recent price of around $170 and its all-time high of $294.85, Solana remains a key player in the blockchain ecosystem, known for its high-speed and low-cost transactions. Currently trading at $123.75, Solana continues to attract developers and investors. Meanwhile, BinoFi, a hybrid crypto exchange, is gaining attention for its bridge-free cross-chain trading capability, redefining trading in the crypto space.

Solana ETF Set to Debut in the U.S.

Solana exchange-traded funds tracking futures will officially launch in the United States for the first time on Thursday, March 20, 2025. According to Bloomberg, Volatility Shares, a Florida-based asset manager, has approval to debut the Solana (SOL) futures ETFs. The Volatility Shares Solana ETF, with ticker SOLZ, will track Solana futures and have an expense ratio of 0.95%. Meanwhile, the firm’s other fund, the Volatility Shares 2X Solana ETF, with ticker SOLT, will offer Leveraged exposure at 2x and carry an expense ratio of 1.85%. The launch comes amid a flurry of spot ETFs applications currently before the U.S. Securities and Exchange Commission.

First Solana Futures ETFs in US Set to Begin Trading Thursday

Volatility Shares, a Florida-based issuer of exchange-traded funds, will debut two ETFs on Thursday that track Solana’s price using futures contracts in the U.S. The Volatility Shares Solana ETF (SOLZ) will track Solana futures, which recently launched in the U.S. through Coinbase’s derivatives arm, while the Volatility Shares 2x Solana ETF (SOLT) will allow investors to access amplified returns. Both funds will be listed on the Nasdaq.